Makale detayı · 2016 · article
The Diagnostic Value of the Correlation between Serum Anti p53 Antibody and Positron Emission Tomography Parameters in Lung Cancer
Veri kaynağı ayrımı
- YÖKSİSYÖKSİS makale kaydı
- YÖKSİS dergi adıMalecular Imaging and Radionuclide Therapy
- Katalog eşleşmesi (ISSN)Molecular Imaging and Radionuclide Therapy
- OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)
- Semantic Scholaratıf sayısı (OpenAlex ile birleştirilmez)
Özet
OBJECTIVE: Mutations in the p53 gene are the most commonly observed genetic abnormalities in malignancies. The purpose of this study was to assess the diagnostic value of serum anti-p53 antibody (Ab) along with the correlation between serum anti-p53 Ab level and quantitative positron emission tomography (PET) parameters such as maximum standardized uptake value (SUVmax), SUVave, metabolic tumor volume, total lesion glycolysis (TLG) and tumor size. METHODS: Serum anti-p53 Ab level was studied in three groups. Patients who underwent 18F-fluorodeoxyglucose (FDG) PET/computed tomography (CT) imaging for staging of previously diagnosed lung cancer constituted the first group, while patients who underwent 18F-FDG PET/CT imaging for evaluation of suspicious pulmonary nodules detected on thorax CT and did not show pathologic FDG accumulation (NAPN=pulmonary nodule with non avid-FDG) were enrolled in the second group. The third group consisted of healthy volunteers. RESULTS: Twenty-eight patients with lung cancer (median age: 62.5, range: 39-77years), 28 patients with NAPN (median age: 65, range: 33-79 years), and 24 healthy volunteers (median age: 62, range: 44-74 years) were enrolled in the study. The serum anti-p53 Ab level was low in healthy volunteers while it was higher in both lung cancer patients and NAPN patients (p<0.05). When serum anti-p53 Ab level and PET parameters were evaluated, there was no significant correlation between serum anti-p53 Ab level and SUVmax, SUVave, TLG, tumor volume and tumor size of patients with lung cancer (p>0.05). Besides, there was no significant difference between serum anti-p53 Ab level and lesion size of NAPN patients (p>0.05). CONCLUSION: It was determined that serum anti-p53 Ab levels are not significantly correlated with PET parameters, and that serum anti-p53 Ab levels increase in any benign or malignant lung parenchyma pathology as compared to healthy volunteers. These results indicate that this Ab cannot be used as a predictor of malignancy in a lung lesion.
Konular
Atıflar
OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.
7atıfOpenAlex · cited_by_count (önbellek / veritabanı)
Yerel katalogda bu makaleye atıf yapan 7 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).
- 2019 Effect of urinary excretion on radiation dose in patients having PET/CT scansAtıf 2 · OpenAlex
- 2019 Effect of urinary excretion on radiation dose in patients having PET/CT scansAtıf 2 · OpenAlex
- 2018 The Diagnostic Contribution of (18)F-FDG PET/CT Scan in Cancer of Unknown PrimaryAtıf 1 · OpenAlex
- 2017 Is there diagnostic and prognostic importance of serum anti-p53 antibody level in lung cancer?Atıf 0 · OpenAlex
- 2017 Is there diagnostic and prognostic importance of serum anti-p53 antibody level in lung cancer?Atıf 0 · OpenAlex
- 2017 Is there diagnostic and prognostic importance ofserum anti-p53 antibody level in lung cancer?Atıf 0 · OpenAlex
- 2017 Is there diagnostic and prognostic importance of serum anti-p53 antibody level in lung cancer?Atıf 0 · OpenAlex